Carcinoma de mama triple negativo experiencia en instituto de oncología ？Dr. Miguel Pérez Carre？o？

objective: presenting the experience of our institution in the treatment of negative triple breast carcinoma and assess their behavior. methods: is a retrospective and descriptive study. we evaluating 998 stories of patients with a diagnosis of breast carcinoma that attended the institute of oncology ？dr. miguel perez carre？o？ from 2000 to 2004, selecting patient？s negative triple, tracking them until december 2009. results: we are reviewed a total of 998 medical histories of patients with a diagnosis of breast carcinoma in a period of four years (2000-2004). 940 had immunohistochemistry which 53 (6 %) were triple negative review. the average age was 48.3. histological type frequent was ductal adenocarcinoma infiltrating 47 (88.%) patients. stage iib was 42 (43 %) cases. neoadyuvancia apply in 45 (83 %) patient. treatment with caf 45 was (83 %); ac 6 (11 %); cmf chemotherapy schemas 3 (6 %). were 35 (65 %) mt+vai-ii and 01 mpo cases found. 48 (90 %) patients receiving adyuvancia, 35 (66%) were they apply chemotherapy and radiation therapy. budget free of disease 34 (64 %) patients with interval longer disease free 49 months 15 (44 %) cases. submitted 10 relapse (19.%) cases. increased frequency of relapse was the bone 03 (30.%). conclusion: consideration of in order to obtain immunohistochemistry a more precise classification and thus identify each patient to provide more effective, with a view to increasing disease-free interval treatment should be and thus the survival overall